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Summary - The effect of praziquantel on urinary tract lesions due to Schistosoma 
haematobium was assessed by ultrasound ,in an endemic village in Niger. Ten months after 
treatment with praziquantel, bladder and renal lesions among the 149 patients were assessed. 
The parasitological cure rate was 87%. 
Ultrasonography proved to be an excellent tool to assess pathological changes. It is reliable, 
quickly performed, well accepted by the community and permits the definition of a ~c regression- 
rate). of the pathological lesions. Ten months after treatment, the (1 regression-rate. of bladder‘ 
lesions was 68% and of renal lesions was 73%. 
The presence of bladder lesions had a negative influence on the regression of renal lesions. 
Nearly all renal lesions, without bladder lesions, regressed within the ten months period of 
observation. 
This study permitted the identification of a group of persons whose bladder lesions did not 
regress and who were possibly more vulnerable to the development of bladder cancer, thus 
requiring long-term follow-up. 
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Introduction 
The efficiency of antischistosomal drugs in urinary schistosomiasis has 
often been demonstrated by the egg count regression, and the study of 
urologic lesions regression confirmed by heavy and invasive complementary 
examinations (intravenous pyelography (2, 14, 18, 21), cystoscopy(25), or 
radio-isotope renography (1, 24)). 
Ultrasonography, a simple, reliable technique, easily replicated, appro- 
priate for use in the field, has been recently introduced in community-based 
surveys (3, 4, 7, 8, 9, 10, 16). 
The objective of this study was to assess the changes in bladder and renal 
lesions due to Schistosoma haematobium through the use of ultrasonography 
in two endemic villages 1 O months after treatment with praziquantel. 
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1. Study population and methods 
1.1. Study population 
The study was performed in two villages, Seberi and Saga near Niiamey 
in a rice irrigation area. The preliminary parasitological and ultrasound data 
were previously’ reported (1 6). The present study included 149 subjects (91 
from Seberi, 58 from Saga) with positive egg output who were treated in 
August 1985 with a single dose (40 mglkg) of praziquantel. 
In addition to the parasitological and ultrasound examination prior to 
treatment, follow-up parasitological examinations were repeated at seven and 
ten months and ultrasound examination was repeated ten months after 
treatment. 
Forty-two persons with positive egg output at the first control, seven 
months after the initial treatment, were retreated with praziquantel (40 mg/kg). 
1.2. Methods 
A quantitative parasitological urine filtration technique was used (26). 
Urine was collected between 9 AM and 1 PM. 
Ultrasound examinations were performed with a 3.5 MHz realtime sectorial 
scanner (ADR 4000) in a health center near the villages of the study. All 
examinations were conducted by the same radiologist (F. L) who was unaware 
of the parasitological status of the patients. The types and classification of 
bladder lesions encountereld during the initial ultrasound examination and the 
images found in the follow-up examination are consistent and are defined 
as follows: 
Three types of bladder lesions were observed (1 6) : thickened wall, regular 
with thickness > 6 mm; irregular wall showing a pattern of thick and thin 
areas; and localized hypertrophy (single or multiple) showing a ((large based )> 
polypoid image in the bladder. 
The lesions were classified into 3 stages according to their severity: 
- stage O, absence of bladder lesion, 
- stage 1, minor lesions with a wall thickness between 6-10 mm and/or 
moderate irregularity and/or a single localized hypertrophy, 
- stage 2, major lesions with a thickness > 11 mm and/or marked 
irregularity andlor two or more localized hypertrophies. 
Bladder calcifications and their evolutions were not considered as they 
For the renal lesions three stages of hydronephrosis were used according 
appear to remain elements of radiological examination. 
to the Weill et a/. classification (29): 
- absence of hydronephrosis (stage O), 
- mild hydronephrosis, characterized by a slight pyelocalyceal dilatation 
- moderate hydronephrosis, with marked pyelocalyceal dilatation corre- 
(stage I), 
sponding to conventional urographic pictures (stage Il), 
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2.1 . Parasitology 
Results of the first control done seven months after treatment show 
parasitologic cure in 100 patients (67O/o). The reduction of ova output was 
97%. Parasitologic cure rate was 87% for patients with ova output < 100 
per 10 ml of urine and 41 940 for those with ova output > 100 per 10 ml. 
The difference between both groups is significant (x2 = 34, ~ < 1 0 - ~ ) .  
Three months after the second treatment, just before ultrasonography 
control, parasitologic cure was obtained in 130 patients (870/0). The reduction 
of ova output increased to 98.5%. 
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2.2. Ultrasonography 
2.2.1. Bladder lesions 
Regression observed 
Of the 149 cases treated, 11 9 had bladder lesions prior to treatment, of 
which 58 were stage 2 and 61 stage 1 (table 1): 
TABLE 1 
Evolution of bladder lesions after treatment according to their initial stage 
Before After Staae O Staae 1 Staae 2 
(n) 20 9 1 
(W 67 % 30% 3 % 
Stage O 
(n) 41 17 3 
( 0 4  67 oh 28 % 5 % % 
Stage 1 
(n) 40 15 , 1 3  
(W 69 % 26 % 5 Oh 
Stage 2 
n : number of patients 
The difference in lesions before and after treatment is highly significant, 
whether considering the lesions as a whole (x2 = 67.2, p c lo-') or the 
stage 2 lesions alone (x2 = 51.2, p < 
Regression of bladder lesions is defined as stage 2 and stage 1 lesions 
reverting to stage O after treatment. Under these conditions a regression rate 
of 68% was found in our study. 
The cure rates are: 65.2% for irregularities of the bladder wall (45/69), 
63O/o for the thickness of the bladder wall (29/46), 50% for localized 
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hypertrophies (34168). The cure rate for each of these three types of lesions 
is not statistically different (irregularity vs focalized hyperthrophy, x2 = 3.6 
p<O.I; thickening vs localized hypertrophy, x2 = 1.911, p < 0.2; irregularity 
vs thickening, x2 = 0.056, p < 0.9). 
Regression in relation to age, sex, urinary egg couflt, bladder lesion stage 
and type of initial lesion. 
The rate of regression1 was similar in all age groups (table 3) as well as 
among women (34/44, 77.3 %) and men (47/75, 62.7 Yo), x2 = 2.6 p <0,2. 
The importance of initial urinary egg count has no influence on regression 
of bladder lesions, whether considered as a whole (Wilcoxon test: p = 0.53) 
or separately by stage 1 and 2 (Wilcoxon test: p = 0.26 and p = 0.16). 
The regression rates of each stage of bladder lesion were similar (Table 
1). The distribution of the different initial lesion types (thickening, irregularity, 
localized hypertrophy) in the patients with no regression was almost identical 
to that of the patients with regression and to that of the entire population 
undergoing ultrasound examination, regardless of the extent and the size of 
lesions encountered. 
TABLE 2 
Evolution of renal lesions after treatment in relation to their stage 
Before After Stage O Stage 1 Stage '2 
(n) 70 6 O 
Stage O . - (014 92 % 6 % 
(n) 43 11 7 
(W 77 % 193 % 3,5 % 
(n) 10 5 2 
Stage 1 \ 
Stage 2 
(Yo) 59 % 29,5 % 113 % 
n : number of patients 
Bladder wall measuring between 6 and 10 mm (defined as ((thickness 1 .)
which persists after treatment may be considered as a sequela. 
Evolution of stage O cases 
Thirty cases of stage O were treated and examined by ultrasound: nine 
evolved into stage 1 and one into stage 2. 
This evolution is independant of age, sex, and egg count (Wilcoxon test: 
p < 0.80). Seven times out of nine, the lesion 1 type reveals a thickness 
between 6 and 10 mm. 
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2.2.2. Renal lesions 
Regression observed 
Among the 149 patients treated, 73 had renal lesions prior to treatment: 
17 stage II and 56 stage I. Ten months after treatment only 4 cases of stage 
II and 22 cases of stage I persisted. There is a significant difference when 
both stages are considered together (x2 = 34.5, p < or in stage II 
lesions alone (x2 = 8.6, p < 0.01). 
As for bladder lesions, ((renal regressiona is defined as stages II and I 
reverting to stage O after treatment. Thus, in this study, the regression rate 
obtained is 73% (53 regressions out of 73 initial cases of hydronephrosis). 
Regression in relation to age, sex, initial urinary egg count, stage of 
hydronephrosis and initial bladder lesions 
Regression of renal lesions after treatment is most important among 
children between 5 and 9 (Table 3). 
TABLE 3 
Regression of bladder lesions and hydronephrosis after treatment with praziquantel according to age 
519 years 10114 years > 15 years Total 
Bladder lesions n = 39 n = 58 n = 22 n = 119 
14 64 % 
8 I36 %I Regression 27 69 % No bgression 12 131 %I 
Hydronephrosis n = 23 n = 41 n =  9 n = 73 
Regression 22(95,5%) 25 61 % 6 66 5%) 
No Regression 1 (45 %) 16 139 %{ 3 13315 %) 
We notice that the older the patients, the less lesions regress (Wilcoxon 
test: p < 0.001). 
No significkt difference in regression of renal lesions between men 
(33/50) and women (20/23) was observed (x2 = 3.46, p< Oll). 
The more important the initial urinary egg count, the less regression is 
observed (Wilcoxon test: p < 0.04 for lesions stage I). 
Regression of stage I (43/56) is slightly better than regression of stage 
II (10117) but with no statistical significance (x2 = 2.02 p< 0.2). 
Among twenty patients with stage I and II hydronephrosis that did not 
regress after treatment we observed, before therapy, in 15 of them (750/0), 
the presence of major bladder lesions, associated with a preponderance of 
major irregularities. 
Evolution of stage O cases 
Among 6 patients out of 76 stages O becoming stage I, we notice 
significant higher egg outputs (Wilcoxon test: p < 0.001) with no relation 
to age or sex. 
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3. Discussion 
The efficacy of the treatment on egg count depended on whether the initial 
urinary egg count was less or greater than 100 egg410 ml. As observed by 
others authors (15, 17, 22), with praziquantel lihe total reduction in egg count, 
was very important. I 
This study confirms the findings of other studies using intravenous 
urography (1, 19, 20, 21, 23, 27), and 2 recent studies using ultrasonography 
(9, 1 l), showing the regression of bladder lesions after antischistosomal 
treatment. 
The 87% parasitological cure rate of praziquantel, was higher than the 
68% rate of regression of bladder lesions. Several hypotheses can be 
considered to explain this difference : 
a) In spite of the treatment, the thickening of the wall (between 6 and 
10 mm) may be due to a persistant inflammatory mucosa. 
b) The images of thickening and irregularity of the mucosa, although very 
suggestive of schistosomiasis in endemic area, can be observed in other 
bladder pathologies, especially in bladder infections, often associated to 
schistosomiasis and that can persist after the treatment of the desease. 
Doehring suggested this hypothesis for 3 oiut of 4 patients presenting a 
thickening of the bladder wall after treatment (9). 
c) Despite the treatment whose efficiency is proved by the parasitological 
examination, some patients present evolutive bladder lesions which do not 
decrease. They could be considered as a risk-group for bladder cancer and 
should ideally be regularely examinated (cystoscopy and anatomopathology). 
d) Other treated patients go from stage O to stage 1 or 2. This could be 
due to the difficulty in using and reading ultrasonography. 
Although it is possible, albeit rare in light of the results, to obtain false 
Ultrasonography also proved to be an interesting tool for the follow-up on 
renal lesions. A 73% regression rate was observed in our study. This rate 
appears low in comparison to the one found in another ultrasonography study 
(9), in which only one person presented persistant dilatation after treatment. 
This is probably due, according to the author, to the young age of the patient 
studied. 
Renal lesions and their regressions after treatment depend on several 
factors : 
1) The more important the intitial egg count, especially among children 
aged between 5 and 9, the more severe the renal lesions, and the less 
nuimerous the regressions. 
2) It depends also on age, as other authors already noticed (12, 20, 25). 
We notice a much better cure among children between 5 and 9 compared 
to older patients. This could be due to the appearance among adolescents 
and adults of fibrosis in the lower ureter or in the intravesical portion of the 
ureter (5, 6, 12, 13, 19, 20), generating an evolving stenosis and/or an 
aperistalsis (23, 28) which could produce a serious renal insufficiency. 
- negatives, it is nearly impossible to obtain false positives. 
. 
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3) The type of underlying bladder lesion seems important in our study, 
major irregularities of bladder mucosa generate less effective regressions of 
renal lesions after treatment. 
The relationship between bladder and renal lesions due to schistosomiasis 
is still under discussion (4, 10, 18, 23). 
Ultrasonography is therefore an excellent means of detection of morbidity 
due to schistosomiasis. It is also an uncomparable tool of follow-up of the 
treatment. 
In order to restrict false negatives with this technique it is necessary that 
a well experienced echographer repeats the examinations himself operating 
on full bladders. 
It appears important, regarding our results, to treat bilharziasis as soon 
as possible in order to act with efficiency on renal lesions that affect the 
patient’s vital prognosis. 
In the future, ultrasonography could be introduced as a mean of diagnosis 
and of supervision within the framework of a national bilharziasis control 
program. 
I 
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Evaluation échographique de la régression des lesions vésicales et rénales dues a 
Schistosoma haematobium apres traitement par le praziquantel. 
Résumé - Cette etude, réalisée au Niger dans une communauté ou la bilharziose sévit a 
I’état endémique, a permis d’observer en échographie, 10 mois apres traitement par le 
praziquantel, I’état des lésions vésicales et rénales chez les 149 patients. 
L‘echographie s’est avérée un excellent moyen de surveillance thérapeutique, fiable, rapide, 
bien accepté des populations, permettant de définir un indice de régression des lesions. Cet indice 
est de 68% au niveau vésical et de 73% au niveau rénal, 10 mois apres traitement. 
La presence de lésions vésicales a une influence négative sur la régression des lésions 
rénales. Presque toutes les lésions rénales, sans présence de lésions vésicales, ont régressé 
au cours des 10 mois d’observation. 
Cette étude a permis de dégager un groupe de patients dont les lésions vésicales n’ont pas 
régressé, et qui pourrait constituer un groupe à risque pour l’apparition de cancer de la vessie, 
ce qui nécessiterait un suivi a long terme. 
Echografische evaluatie van de regressie van de blaas- en nierletsels veroorzaak door 
Schistosoma haematobium na behandeling met praziquantel. 
Samenvatting - Het effect van praziquantel op de letsels van de urinewegen veroorzaakt door 
Schistosoma haematobium werd met echografie in een endemisch dorp in Niger nagegaan. Sij 
de 149 patiënten werden tien maanden na toediening van praziquantel de blaas- en nierletsels 
geobserveerd. Parasitologische genezing werd vastgesteld bij 87 Yo van de patiënten. 
Echografie bleek een uitstekende manier te zijn om pathologische veranderingen te meten. 
Het is betrouwbaar, snel uitgevoerd, goed ontvangen door de bevolking en laat een definitie toe 
van de graad van regressie van pathologische letsels. Tien maanden na behandeling bedroeg 
deze regressiegraad bij blaasletsels 68 Oh en bij nierletsels 73 O h .  
De aanwezigheid van blaasletsels had een negatieve invloed op de regressie van de nierletsels. 
Haast alle nierletsels, zonder blaasaantasting, kenden een regressie binnen de tien maanden 
durende periode van de observatie. 
Deze Studie liet de identificatie toe van een groep personen wiens blaasletsels niet regresseer- 
den en die mogelijk meer vatbaar zijn voor de ontwikkeling van blaaskanker en dus een langdurige 
follow-up vereisen. 
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